logo

Galmed Pharmaceuticals Ltd. (GLMD)



Trade GLMD now with
  Date
  Headline
8/6/2020 7:26:14 AM Galmed Pharma Q2 Net Loss $5.5 Mln Or $0.26/shr Vs Net Loss $4.2 Mln Or $0.20/shr Last Year
5/14/2020 7:06:52 AM Galmed Pharma Q1 Net Loss $6.1 Mln Or $0.29/shr Vs. Net Loss $3.5 Mln Or $0.17/shr Last Year
3/12/2020 7:11:11 AM Galmed Pharma Q4 Net Loss Of $8.3 Mln Or $0.39/Shr Vs Kiss Of $3.7 Mln Or $0.18/Shr Last Year
11/6/2019 7:37:27 AM Galmed Pharmaceuticals Q3 Net Loss $4.5 Mln Vs $1.0 Mln Last Year
4/9/2019 7:31:48 AM Galmed Announces Successful Completion Of End Of Phase 2 Meeting With FDA And Plan For Start Of Phase 3
3/13/2019 7:02:30 AM Galmed Pharma Q4 Net Loss $3.7 Mln Or $0.18/Shr Vs Loss $3.6 Mln Or $0.27/Shr Last Year
3/12/2019 8:01:56 AM Galmed Reports Positive Results From Pharmacokinetic Split Dose Study Of Aramchol
11/5/2018 7:19:53 AM Galmed Pharma Q3 Loss Per Share $0.05 Vs Loss $0.23 Last Year
8/2/2018 7:17:17 AM Galmed Pharma Q2 Loss Per Share $0.17 Vs Loss $0.22 Last Year
6/19/2018 9:49:47 PM Galmed Pharma Prices Underwritten Public Offering Of 5 Mln Shares At $15.00/shr
6/18/2018 6:32:51 AM Galmed Pharma Intends To Offer Public Offering To Raise Aggregate Proceeds Of About $75 Mln